3D cardiac
mapping is a technique that is widely accepted for identification,
characterization, and localization of an arrhythmia. Cardiac mapping is a
procedure in which the information from cardiac electrograms is collected and
displayed. It is used to diagnose heart rhythms particularly in case of
arrhythmia. This procedure is commonly done by injecting catheter into the
heart chamber percutaneously to record electrograms sequentially, which is done
to correlate electrograms in cardiac anatomy. New 3D cardiac mapping systems
create three-dimensional model of any chamber of heart and can track exact
location of the catheter.
Request for
Sample Report@ https://www.alliedmarketresearch.com/request-sample/6882
COVID-19
Impact Analysis:
Due to COVID
19 pandemic other healthcare segments have to face negligence. In addition,
Coronavirus (COVID-19) was discovered in late December in Hubei province of
Wuhan city in China. China is the center of this lethal disease. Furthermore,
this disease predominantly affects the lungs, often leading to pneumonia and
acute respiratory distress syndrome, adverse effects on the heart have also
been observed. Conversely it has been observed that there is prevalence of
Novel coronavirus in patients suffering with conditions like arrhythmia around
16.7 percent of patients developed arrhythmia. For this condition mainly 3D
cardiac mapping is used. All these factors are anticipated to impact the china
3D cardiac mapping market as well in the future.
Hospitals segment dominated the 3D cardiac mapping market in 2019, and
is anticipated to maintain its dominance throughout the forecast period, owing
to the fact that cardiac mapping is majorly used in hospitals and clinics to
perform complex arrhythmias. Moreover, surge in incidences of cardiovascular
diseases in China has led to considerable rise in hospital visits by patients
since recent years. Preference among patients to visit hospitals for their
checkup or disease diagnosis is anticipated to propel the market growth in the
future.
Key Market Players
- Abbott Laboratories
- Acutus Medical
- MicroPort Scientific Corporation
- Medtronic Plc.
0 Comments